Navigation Links
InterCure Names Scot Dube Vice President of Sales
Date:12/11/2007

rve as a catalyst for expanding InterCure's retail presence and represents the last key piece of our world class sales and marketing organization. We are pleased to welcome Scot as a member of our executive management team."

"Having navigated the consumer healthcare market for three decades, I believe InterCure is uniquely positioned to tap the enormous growth occurring within the Personal Therapeutic Device category," said Scot Dube, new Vice- President of Sales, InterCure. "Retailers are actively seeking opportunities to drive incremental profit through new category evolution. I look forward to expanding InterCure's market position as both the innovator and leader in the important hypertension treatment market. Hypertension is reaching epidemic proportions in the United States and around the globe, and the need for effective treatments could not be greater. I look forward to leveraging my extensive sales and marketing management experience to launch and promote retail distribution, bringing the RESPeRATE device to store shelves across America."

About RESPeRATE

RESPeRATE(R) is FDA-cleared for over-the-counter sale and is the only medical device on the market clinically proven to lower blood pressure through paced breathing therapy. The device uses the body's natural tendency to follow external rhythms, interactively guiding the user to effortlessly reduce their breathing rate to a "therapeutic zone" of less than 10 breaths per minute. The breathing exercises with RESPeRATE relax the constricted muscles surrounding the small blood vessels, allowing the blood to flow more freely and yielding a significant and lasting reduction of blood pressure within weeks.

About InterCure, Ltd.

InterCure, a medical device company, publicly traded on the Tel Aviv Stock Exchange (TASE: INCR) has become a leader in the growing Personal Therapeutic Device category. Its broadly patented "device-guided breathing" technology platform enables a systematic
'/>"/>

SOURCE InterCure, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia
2. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
3. Mediware Names Thomas K. Mann Chief Executive Officer
4. Cleveland-based Health Care Tech Company Within3 Names New CEO
5. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
6. Patient Safety Authority Board of Directors Names Infection Advisory Panel
7. Hooper Holmes Names Chris Behling President of Health & Wellness Division
8. MDMA Names New Director of Federal Affairs
9. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
10. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
11. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... the relevance of palliation in advanced cancer are ... trials (RCTs). This is the result of an ... Efficiency in Health Care (IQWiG), which has now ... external experts, IQWiG analysed studies on four solid ... and pancreatic cancer. For this purpose, the research ...
(Date:4/24/2014)... has been awarded one of 30 grants from the ... Academic Participating Site in its new National Clinical ... select groups of investigators charged with distributing resources in ... NCTN grant system reflects recommendations from a 2010 ... achieve four goals:, Faster design, launch, and ...
(Date:4/23/2014)... by Massachusetts General Hospital (MGH) investigators may lead to ... a serious medical problem use of fecal material ... the Clostridium difficile ( C. difficile ) ... the journal Clinical Infectious Diseases , the researchers ... donors unrelated to patients was as successful in curing ...
(Date:4/23/2014)... National Institute of Arthritis and Musculoskeletal and Skin Diseases ... Ross Prize in Molecular Medicine, conferred by the Feinstein ... award will be given on June 9 at the ... scientific presentations by Dr. O,Shea and other prominent researchers. ... , The award, which includes a $50,000 prize from ...
(Date:4/23/2014)... identified an important enzyme pathway that helps prevent new ... a condition that has been directly linked to cancer ... biochemistry, found that near the end of cell division, ... any breaks in DNA are fully repaired before the ... cells. This process helps safeguard against some of the ...
Breaking Medicine News(10 mins):Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2
... of medical miracles and the very latest in scientific ... (FBR) announced today it will distribute its free daily ... experiencing tremendous success in select markets. The Animal ... medical miracles and latest scientific breakthroughs. The host ...
... the University of Exeter reveals for the first ... physical exercise, may help reduce cigarette cravings. Published ... shows how exercise changes the way the brain ... for nicotine. For the first time, researchers used ...
... Erdman, A Cogdell Spencer,Company is pleased to ... earned the U.S. Environmental Protection Agency,s (EPA,s),prestigious ENERGY ... environmental protection. America,s commercial buildings and industrial,plants that ... facilities for energy,efficiency may qualify for the ENERGY ...
... Help Set Unprecedented NumbersVIRGINIA BEACH, Va., Feb. 10 ... able to save the lives of 406 people ... 2008.LifeNet Health saw a 13% increase from 2007 ... to hospitals and physicians. LifeNet Health provided ...
... Samples taken from the 39 hunter-killed elk during ... negative for chronic wasting disease (CWD), according to ... veterinarian. Samples also tested negative for brucellosis ... is awaiting the results of CWD testing for ...
... China Sky One,Medical, Inc. (,China Sky One Medical, ... a,leading fully integrated pharmaceutical company producing over-the-counter,drugs in ... its,revenue and net income guidance for the full-year ... to continued strong organic growth and contribution from ...
Cached Medicine News:Health News:Foundation for Biomedical Research Announces National Distribution of Daily Radio Broadcast 2Health News:First brain study reveals benefits of exercise on quitting smoking 2Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 2Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 3Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 4Health News:LifeNet Health Announces a Record Year of Saving Lives and Restoring Health 2Health News:LifeNet Health Announces a Record Year of Saving Lives and Restoring Health 3Health News:Hunter-Killed Elk Test Negative for CWD and Other Diseases 2Health News:Hunter-Killed Elk Test Negative for CWD and Other Diseases 3Health News:Hunter-Killed Elk Test Negative for CWD and Other Diseases 4Health News:Hunter-Killed Elk Test Negative for CWD and Other Diseases 5Health News:China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update 2Health News:China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update 3
(Date:1/15/2014)... Foundation today announced it has established a relief fund ... weather that has gripped much of the nation. AARP and ... to support these emergency relief efforts AARP and AARP Foundation ... up to $500,000 in aid. The matching program will be ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... (Nasdaq: BNVI ) today announced the publication of ... to glucose limitation" in the journal Cell Cycle . ... the protein CC3/TIP30 in cancer cells and their ability to ... glucose and other nutrients. Lack of CC3/TIP30 in a variety ...
... 15, 2010 On June 13-14, 2011, in Beijing, China, ... historic conference on food and drug law, regulation and policy ... from China, including Shao Mingli, Commissioner, State Food and Drug ... have been invited to speak at the meeting. Several U.S. ...
Cached Medicine Technology:Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors 2Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors 3Food and Drug Law Institute to Hold Historic Conference on U.S.-China Food and Drug Law 2
... part of the AXIOM family, which ... the clinical angiography, card- angiography, and ... functional and business pages you can ... delivers unrivalled value to users and ...
Spring Type with lock. Titanium....
.60 x 22mm, angled 60, .33mm end port [Simcoe]...
... The STARFlex is a fourth generation ... CardioSEAL by the addition of a unique ... coil micro-spring. The micro-spring is attached to ... and provides a self-adjusting positioning mechanism which ...
Medicine Products: